Astrazeneca Results 2024. The company intends to publish its q1 2024 results on 25 april 2024. Financial performance for q1 2024 (growth numbers at cer) total revenue up 19% to $12,679m, driven by an 18% increase in.
On thursday 25 april 2024 we announced our q1 2024 results. The company intends to publish its q1 2024 results on 25 april 2024.
Astrazeneca Had A Very Strong Start In 2024 With Substantial Total Revenue Growth Of 19% In The First Quarter.
Pharmaceutical giant astrazeneca reported its first quarter 2024 earnings on thursday, seeing extremely robust earnings per share (eps) and revenue growth.
Our Strong Pipeline Momentum Has Continued Into 2024, We Announced Positive Trial Results For Laura And Adriatic, Both Of Which Have Been Selected.
Oncology revenue up 26% in qtr.
On Thursday 25 April 2024 We Announced Our Q1 2024 Results.
Images References :
An Accompanying Webcast For Investors And Analysts Took Place At 11:45 Uk Time.
Astrazeneca increases 2024 dividend by 7%.
Astrazeneca Gained 8.95% In The Past Month, Fueled By Optimism About Its 2024 Earnings Outlook.